![Matteo RICCÒ | Medical Doctor | Azienda Unità Sanitaria Locale Reggio Emilia, Reggio nell'Emilia | ASL Reggio Emilia | Dipartimento di Sanità Pubblica / Department of Public Health | Research profile - Page 5 Matteo RICCÒ | Medical Doctor | Azienda Unità Sanitaria Locale Reggio Emilia, Reggio nell'Emilia | ASL Reggio Emilia | Dipartimento di Sanità Pubblica / Department of Public Health | Research profile - Page 5](https://i1.rgstatic.net/ii/profile.image/11431281112367856-1673425807013_Q512/Matteo-Ricco.jpg)
Matteo RICCÒ | Medical Doctor | Azienda Unità Sanitaria Locale Reggio Emilia, Reggio nell'Emilia | ASL Reggio Emilia | Dipartimento di Sanità Pubblica / Department of Public Health | Research profile - Page 5
![Frontiers | Hypertension in Children and Adolescents: A Position Statement From a Panel of Multidisciplinary Experts Coordinated by the French Society of Hypertension Frontiers | Hypertension in Children and Adolescents: A Position Statement From a Panel of Multidisciplinary Experts Coordinated by the French Society of Hypertension](https://www.frontiersin.org/files/Articles/680803/fped-09-680803-HTML/image_m/fped-09-680803-t001.jpg)
Frontiers | Hypertension in Children and Adolescents: A Position Statement From a Panel of Multidisciplinary Experts Coordinated by the French Society of Hypertension
![PDF) From effeminato to virtuoso: gender patterns in Alessandro Scarlatti's Telemaco (1718) | Bruno Forment - Academia.edu PDF) From effeminato to virtuoso: gender patterns in Alessandro Scarlatti's Telemaco (1718) | Bruno Forment - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/34746238/mini_magick20190321-2110-1jx3nfd.png?1553161839)
PDF) From effeminato to virtuoso: gender patterns in Alessandro Scarlatti's Telemaco (1718) | Bruno Forment - Academia.edu
![PDF) Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: The IMMUNOSTIM study PDF) Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: The IMMUNOSTIM study](https://i1.rgstatic.net/publication/317034182_Natural_killer-cell_counts_are_associated_with_molecular_relapse-free_survival_after_imatinib_discontinuation_in_chronic_myeloid_leukemia_The_IMMUNOSTIM_study/links/5980d0d7a6fdccb310ff1722/largepreview.png)